Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tela Bio Inc
(NQ:
TELA
)
2.720
-0.040 (-1.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tela Bio Inc
< Previous
1
2
Next >
TELA Bio: Q1 Earnings Insights
May 10, 2022
TELA Bio (NASDAQ:TELA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TELA Bio missed estimated earnings by...
Via
Benzinga
Zedge And 2 Other Stocks Insiders Are Buying
April 20, 2022
Although Dow Jones closed higher by around 500 points on Tuesday, there were a few notable insider trades.
Via
Benzinga
Earnings Scheduled For March 21, 2022
March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •...
Via
Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Via
Benzinga
Preview: TELA Bio's Earnings
March 18, 2022
TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For May 10, 2022
May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Via
Benzinga
TELA Bio: Q4 Earnings Insights
March 21, 2022
TELA Bio (NASDAQ:TELA) reported its Q4 earnings results on Monday, March 21, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TELA Bio missed...
Via
Benzinga
Insiders Buy Around $98M Of 3 Stocks
February 25, 2022
Although US stock futures traded lower this morning amid continued Russian bombing in Ukraine, there were a few notable insider trades. W...
Via
Benzinga
TELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript
November 11, 2021
TELA earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript
August 11, 2021
TELA earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
TELA Bio: Q2 Earnings Insights
August 11, 2021
Shares of TELA Bio (NASDAQ:TELA) decreased 2.3% after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.55% over the past year to ($0.57), which...
Via
Benzinga
Earnings Outlook For TELA Bio
August 10, 2021
On Wednesday, August 11, TELA Bio (NASDAQ:TELA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
June 14, 2021
Gainers RAPT Therapeutics (NASDAQ:RAPT) s...
Via
Benzinga
ROCE Insights For TELA Bio
May 24, 2021
In Q1, TELA Bio (NASDAQ:TELA) posted sales of $5.88 million. Earnings were up 7.74%, but TELA Bio still reported an overall loss of $7.27 million. In Q4, TELA Bio brought in $5.67...
Via
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For August 11, 2021
August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is...
Via
Benzinga
TELA Bio Launches Post Market Study Of OviTex In Hernia Surgery
May 19, 2021
TELA Bio Inc (NASDAQ: TELA) has launched its second post-market study, BRAVO II, to evaluate the clinical performance of OviTex Reinforced Tissue Matrices in the...
Via
Benzinga
TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript
May 14, 2021
TELA earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
TELA Bio: Q1 Earnings Insights
May 13, 2021
Shares of TELA Bio (NASDAQ:TELA) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 11.11% year over year to ($0.56...
Via
Benzinga
TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript
May 03, 2021
TELA earnings call for the period ending December 31, 2020.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For May 13, 2021
May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.